EUR 68.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 10.35 Million | 10.36 Million | 10.42 Million | 9.7 Million | 9.53 Million | 1.24 Million |
Net Income | 11.38 Million | 10.3 Million | 10.38 Million | 10.31 Million | 9.79 Million | 9.36 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -1.02 Million | 58.27 Thousand | 42.3 Thousand | -608.01 Thousand | -257.58 Thousand | -8.12 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | -10.35 Million | -10.35 Million | -10.35 Million | -9.75 Million | -9.45 Million | -10.35 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -10.35 Million | -10.35 Million | -10.35 Million | -9.75 Million | -9.45 Million | -10.35 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 20.52 Thousand | 109.72 Thousand | 11.63 Thousand | 11.65 Thousand | 18.73 Thousand | 15 Thousand |
Cash at end of period | 3000.00 | 10 Thousand | 76 Thousand | -48 Thousand | 86 Thousand | 18.73 Thousand |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -17.52 Thousand | -99.72 Thousand | 64.36 Thousand | -59.65 Thousand | 67.26 Thousand | 3738.00 |
Free Cash Flow | 10.35 Million | 10.36 Million | 10.42 Million | 9.7 Million | 9.53 Million | 1.24 Million |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 11.38 Million | 125.10 | 125.10 | 5566.20 | 5566.20 | 10.3 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -1.02 Million | -125.10 | -125.10 | -5566.20 | -5566.20 | 58.27 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | -10.35 Million | - | - | - | - | -10.35 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -10.35 Million | - | - | - | - | -10.35 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 20.52 Thousand | 27.7 Thousand | - | 20.52 Thousand | - | 109.72 Thousand |
Cash at end of period | 3000.00 | 1134.10 | - | 27.7 Thousand | - | 10 Thousand |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -17.52 Thousand | -26.56 Thousand | - | 7176.00 | - | -99.72 Thousand |
Free Cash Flow | 10.35 Million | - | - | - | - | 10.36 Million |
THANGAMAYL
RUBFILA
NRSCF
ERA
BLO
4569